
Eltrombopag Administration

Oral eltrombopag or matching placebo was administered at an initial dose of 50 mg once daily, titrated in 50-mg increments every 2 weeks up to 300 mg to achieve a complete PLT-R, defined as a PLT count ≥100 × 10